Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

CMS Sends Cease/Desist Letters to Labs Lacking CLIA Certificates

CLINICAL LABORATORIES DOING COVID-19 TESTING and lacking the proper CLIA certificates to do so are receiving cease-and-desist letters from the federal Centers for Medicare and Medicaid Services (CMS).  The first letters were sent on Aug. 12 and letters have been sent to other labs each month.  Recently, CMS reported it had sent cease-and-desist letters to …

CMS Sends Cease/Desist Letters to Labs Lacking CLIA Certificates Read More »

To access this post, you must purchase The Dark Report.

Comments

;